Sanofi will pay up to $109 million to settle allegations that it gave healthcare providers free units of its knee injection drug Hyalgan to induce them to prescribe the drug, according to the Department of Justice. The settlement also resolves claims that the company submitted false average sales price reports for Hyalgan that omitted the free units distributed.
The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.
Healthland, an electronic health records vendor primarily focused on the rural hospital market, has acquired American HealthTech.
CFG Capital Markets, the investment banking platform of Capital Funding Group, announced it was an advisor on a $141.7 million portfolio.
